Not a member? Sign Up

Reasons for Joining

    Address your challenges through knowledge sharing with peers from our global network of specialists.

    Benchmark your business initiatives with the who's who in the field.

    Hear from industry pioneers how to maximize ROI in today's challenging economy.

    And best of all It's FREE!
Sign in using your existing
Pharma IQ account
Username or Email:

Sign Up  |  Already a member? Sign In  |  Visit IQPC.com  
Pharma IQ

DSM-5: Diagnosis Trouble

Contributor: Gerald Clarke
Posted: 5/20/2013


DSM-5: Diagnosis Trouble - Gerald Clarke

The controversy surrounding the impending release of the DSM-5 may have spurred on one of the most interesting developments in psychiatric medicine in decades. Our editor investigates the controversy and asks what's next for the world's most influential diagnostic manual. Full Article »

Events related to this topic:

Lundbeck's Ludovic Otterbein on Bottlenecks and Best Practices in Compound Management

Contributor: Andrea Charles
Posted: 3/13/2013


Lundbeck's Ludovic Otterbein on Bottlenecks and Best Practices in Compound Management - Andrea Charles

"Every company has compound collections of different sizes, but we all face the same challenge of the rising cost of R&D," said Ludovic Otterbein, Head of Global Compound Management and Analytical Chemistry at at H. Lundbeck A/S. Full Podcast »

Events related to this topic:

Copy More! Copy Better!

Contributor: Jonas Boström
Posted: 5/7/2013


Copy More! Copy Better! - Jonas Boström

In his latest column, Jonas explains the pharma industry should re-examine its aversion to copying and how this aversion can restrict innovation. He then makes the case that 'follow-on' drugs are good for companies and patients. Full Column »

Events related to this topic:

Pharma Industry Report: A Global Guide to Clinically Relevant Drug Transporters

Posted: 5/24/2013

Pharma Industry Report: A Global Guide to Clinically Relevant Drug Transporters

In this 10 page resource pack we look at drug transporter outsourcing, intelligent drug development applied to clinically relevant drug transporters and drug transporters in ADME. Plus feature interviews with leading experts from AstraZeneca, GlaxoSmithKline and The University of Oxford. Full Whitepaper »

Events related to this topic:

Advertisement

Events of Interest
Download Brochure

Please complete the information below to complete your download.

Please note: That all fields marked with an asterisk (*) are required.

First Name *
Last Name *
Job Title *
Company Name *
Email Address *
Telephone *
Country *
Where did you hear about us? *

I would like to receive information about sponsorship and exhibition opportunities

Yes, sign me up for the FREE Pharma IQ e-newsletter, including information on FREE Podcasts, Webinars, event discounts and online learning opportunities.

what is the definition of pharma area sales manager

Posted by:  prashantshrivastava | Answer this question

The USP published new drafts to revise the General Chapters 41 “Balances” and 1251 “Weighing on an Analytical Balance” in the...

Posted by:  aholder | Answer this question

WHAT IS PH?,

Posted by:  A.Veerendra nath reddy | Answer this question

Is it possible with a MEG (Magnetoencephalography) to measure the neural activitu or the VLPO (neuron firings)?

Posted by:  Insomnia | Answer this question

what is the requirement of chewable tablet bioequivalance study for brazil and what are the general

Posted by:  ramesh89pharma | Answer this question

what is mean by partical size distribution

Posted by:  balasaheb jadhav | Answer this question

what is the use of Proluton Depot for pregnant women?

Posted by:  etc.com | Answer this question

WHAT IS PH?

Posted by:  A.Veerendra nath reddy | Answer this question

what is the requirement of chewable tablet bioequivalance study for brazil and what are the general

Posted by:  ramesh89pharma | Answer this question